Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimizing Multimodal Pain Regimens in Upper Extremity Surgery
NCT07750639Phase 4Enrolling by invitation
- Sponsor
- AdventHealth
- Start
- Aug 2024
- Primary completion
- Nov 2027
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of gabapentin, naproxen, acetaminophen and oxycodone in postoperative pain and opioid use disorder (OUD) (3 arms), sponsored by AdventHealth. Primary endpoint: Number of Participants Requesting an Additional Postoperative Pain Medication Refill at 2 weeks. Started Aug 2024; status: enrolling by invitation.
02
Drugs
gabapentinnaproxenacetaminophenoxycodone
03
Conditions
postoperative painopioid use disorder (OUD)
Beyond the preview
Go deeper on NCT07750639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07750639.